Over the last decade, there has been an increasingly positive shift in how transcranial photobiomodulation (tPBM) is viewed by mainstream medical science.

If you’d like an in-depth overview of the potential applications of transcranial photobiomodulation in the field of psychiatry, this presentation by Dr. Corinne Fischer is for you.

Dr. Fischer is a professor of Psychiatry at the University of Toronto and Director of Geriatric Psychiatry at St. Michael’s Hospital.

She touches on a few different topics, including Vielight technology:

• A conceptual overview of photobiomodulation in comparison to other neuromodulatory therapies.
• An overview of the basic science, anecdotal and clinical trial evidence for photobiomodulation in Alzheimer’s disease.
• An overview of potential applicability to other neuropsychiatric disorders.

Dr. Fischer is also the chief Principal Investigator for Vielight’s pivotal clinical trial for Alzheimer’s disease (228 participants): https://clinicaltrials.gov/ct2/show/NCT03484143

Vielight is proud to be a part of this change, contributing to faster advancement and, ultimately, acceptance of tPBM as a viable and effective non-invasive brain stimulation modality for numerous applications.